Dr. Katherine Ferris, MD

Dr. Ferris practices at Escondido Dermatology, Inc a Professional Corporation in Escondido, California.

Dr. Ferris' NPI, 1346661832, was assigned on December 30, 2013. Dr. Ferris graduated from University of Miami, Miller School of Medicine in 2013. Dr. Ferris holds California license 135021.

Dr. Ferris' primary practice is Escondido Dermatology, Inc a Professional Corporation, at 504 W Mission Ave, Escondido, CA 92025 in San Diego County. The practice phone is (760) 747-1980.

Dr. Ferris' primary practice is Escondido Dermatology, Inc a Professional Corporation in Escondido, California. The medical group on file is Escondido Dermatology. Dmand AI also links Dr. Ferris to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ferris practices. Vendor and product names are available with a free account.

Dermatology is Dr. Ferris' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ferris is board certified in dermatology by the American Board of Dermatology. Dr. Ferris is licensed in California.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, corns and calluses, hives, itchy rashes and minor injury to a limb among the conditions Dr. Ferris treats.

CMS data shows 4,332 Medicare services from Dr. Ferris across 21 procedure codes in 2024, for 452 Medicare patients. Medicare paid $250,578 for them. Every service was in an office.

CMS counts 452 Medicare patients who saw Dr. Ferris in 2024. The largest group is 65 to 74, with 206 patients. 73% of them have high cholesterol, and 63% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ferris' median patient age at 67, with 56% women.

In 2024, Dr. Ferris wrote 125 Medicare Part D claims for 44 patients. 82% of them were for generic drugs. CMS names the drug for 45 of them, across 3 drugs with 11 or more claims each, at $832 in total drug cost. In 2023, CMS named 309 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Ferris for performance year 2024, reported individually. Dr. Ferris accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 960 procedures of removal of skin lesions by Dr. Ferris, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Ferris. Dr. Ferris' most frequent co-authors are Keyvan Nouri, MD and Michael Ian Shiman, MD.

CMS Open Payments shows 115 general payments to Dr. Ferris from 14 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 70% of the total. Janssen Pharmaceuticals, Inc paid the most, $763.

Dr. Ferris graduated from University of Miami, Miller School of Medicine in 2013.

Dr. Ferris is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.